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Richard J. Hayes2, Elizabeth L. Corbett2, and Gavin J. Churchyard1,2
1Aurum Institute for Health Research, Parktown, Johannesburg, South Africa; and 2London School of Hygiene and Tropical Medicine, London,
United Kingdom
Rationale: Gold miners in South Africa undergo annual radiological
screening for tuberculosis in an occupational health center of a gold
mining company, but the optimal screening algorithm is unclear.
Objectives: To evaluate methods for active case detection of tuber-
culosis.
Methods: A sequential sample of miners attending annual medical
examination was screened for tuberculosis using a symptom ques-
tionnaire, chest radiograph, and two sputum specimens for micros-
copy and culture.
Measurements and Main Results: There were 1,955 miners included in
this study; all were male with a median age of 41 years (range, 20–
61 yr). Presence of at least one of a trio of symptoms (new or
worsening cough, night sweats, or weight loss) had similar sensitiv-
ity (29.4%) to either chest radiograph (25.5%) or sputum smear
(25.5%). These sensitivities did not differ by HIV status. Presence of
one or more elements of the symptom trio and/or new radiological
abnormality substantially increased sensitivity to 49.0%. Specificity
of the symptom trio was higher in HIV-uninfected (91.8%) than in
HIV-infected persons (88.2%; P 5 0.018). Specificity of chest radi-
ography and smear were similar (98.7% and 99.0%, respectively)
and did not differ by HIV status (both P values. 0.8).
Conclusions: In a population of gold miners who undergo regular
radiological screening, the addition of chest radiography to symp-
tom screening substantially improved the sensitivity and positive
predictive value. HIV infection did not alter the sensitivity of the
screening tool.
Keywords: tuberculosis; HIV infection; case finding
Tuberculosis incidence has increased in most African countries,
including those with well-run tuberculosis control programs,
largely due to the HIV epidemic (1). The detection, treatment
and cure of sputum smear–positive pulmonary tuberculosis is
central to effective tuberculosis control. The World Health
Organization’s (WHO) Directly Observed Therapy, Short
course (DOTS) strategy for tuberculosis control relied on
detection of tuberculosis cases through self-presentation to
health services with symptoms (2). This policy was based on
studies undertaken in the pre-HIV era, which demonstrated
that various active tuberculosis case-finding methods had small
yield, generated large numbers of tuberculosis suspects requir-
ing investigation, and that most patients detected by the
screening programs had presented previously to a health service
with respiratory symptoms (3–5).
In response to the HIV-associated tuberculosis epidemic, the
WHO Stop TB program now includes intensive tuberculosis
case finding as part of the strategy to reduce the burden of
tuberculosis in HIV-infected individuals (6). Active case finding
may contribute to tuberculosis control by reducing tuberculosis
transmission through earlier diagnosis and treatment. However,
the optimal tuberculosis screening strategies to be used in active
case finding remain uncertain.
Since the early 1990s, the incidence of tuberculosis among
gold miners working in South Africa has increased fourfold, as a
result of the combined effects of the HIV epidemic and silicosis
(7). The aim of this study was to determine the performance
characteristics of various screening methods for the active case
finding of pulmonary tuberculosis among the general popula-
tion of miners and to investigate whether they differed by HIV
status. Some of the results of these studies have been reported
previously in the form of abstracts (8–10) and data from this
study have been used in a previous publication describing the
impact of HIV infection on tuberculosis prevalence and in-
cidence in this population (11).
METHODS
Study Population and Site
All employees of the gold mining industry undergo annual medical
examinations to determine fitness to work. These include radiological
screening for tuberculosis and silicosis and a urine specimen for testing
for glucose. We conducted this study at an occupational health center
of a single gold mining company in the Free State Province, South
Africa from July 2000 to January 2001. Some of the methods have been
AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
The World Health Organization Stop TB strategy includes
tuberculosis case finding; however, the optimal tuberculosis
screening algorithm and the impact of HIV on screening
remain unclear.
What This Study Adds to the Field
The results of this study demonstrate that the addition of
chest radiography to symptom screening significantly in-
creases sensitivity with minimal loss of specificity and that
the performance of tuberculosis screening is unaffected by
HIV. These results will be used to inform international
recommendations on the optimum tuberculosis screening
strategy and encourage use of tuberculosis screening in
high HIV prevalence settings.
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published previously (11). Briefly, alternate miners attending their
annual medical examination were sampled; permanent employees were
included and contractors were excluded.
All consenting miners underwent the following study procedures in
addition to the routine mini–chest radiograph (100 mm 3 100 mm):
screening for tuberculosis with a symptom questionnaire (new or
worsening cough and duration of cough, new or worsening sputum
production, hemoptysis, night sweats, fever and duration of fever, and
weight loss of more than 5 kg in previous 6 months) and collection of
two sputum specimens for microscopy and culture 1 hour apart. The
previous routine mini chest radiograph was obtained. The routinely
collected urine specimen was used for HIV testing.
Individuals who had any symptom listed above, a new or changing
radiological lesion compared with the previous chest radiograph,
a positive sputum smear (positive defined as any of scanty, 11, 21,
or 31), or positive culture (hereafter referred to as the ‘‘screening’’
results) were defined as tuberculosis suspects. These tuberculosis
suspects were referred for further investigation, wherein a standardized
protocol included a standard size chest radiograph and three sputum
specimens for microscopy, culture, and organism identification, re-
ferred to as the ‘‘review’’ results. The study team then reviewed all
results and applied case definitions.
Mycobacteriology and HIV testing were as previously described,
with sputum specimens examined using auramine staining and fluoro-
chrome microscopy, and cultured on Lo¨wenstein-Jensen media. Spe-
cies identification was performed using the Genprobe polymerase
chain reaction method for Mycobacterium tuberculosis and M. kansasii
and standard biochemical tests for other species (12, 13). Radiography
at screening and review were conducted by separate radiologists, both
blinded to all other results. The mini chest radiograph was assessed for
presence and grade of silicosis using a modified International Labour
Organization scoring system (14).
Case Definitions
Due to the possibility of false-positive results at screening, the case
definitions took into account results from both screening and review
procedures, and a single positive sputum culture without supportive
clinical evidence was not considered as evidence of tuberculosis.
Participants were categorized as having definite pulmonary tuberculosis
if they had at least one positive sputum culture with more than five
colonies of M. tuberculosis and at least one of the following: compatible
clinical features, compatible radiological features, or another sputum
that was positive on culture. Participants were categorized as having
presumed pulmonary tuberculosis if they had all of the following:
compatible clinical features, no clinical response to 5 days of antibiotics
before commencing tuberculosis treatment, response to tuberculosis
treatment within 2 months, and were either smear positive or had new
radiological abnormalities.
Ethics Approval
Approval was obtained from the ethics committees of Anglogold
Health Service, London School of Hygiene and Tropical Medicine,
and University of the Witwatersrand. Written, or witnessed oral,
informed consent was obtained from all participants.
Data Analysis
Data were analyzed using Stata 9.1 for Windows (Stata Corporation,
College Station, TX). Fisher exact test was used to assess differences in
demographic characteristics by HIV status, as well as differences in
sensitivity and specificity by HIV status, previous tuberculosis, and
silicosis. All confidence intervals (CIs) were exact, except those for
odds ratios (ORs). Univariable and multivariable logistic regressions
examined associations between symptoms and tuberculosis, adjusting
for confounders.
Information on current or previous tuberculosis treatment was
ascertained by cross-referencing with the company tuberculosis data-
base. Those on tuberculosis treatment at time of screening were excluded
from analysis. Those with a record of prior tuberculosis treatment that
had been completed at any time before screening were classified as
having previous tuberculosis.
We considered any positive mycobacterial culture, regardless of
whether M. tuberculosis was identified, as defining a tuberculosis sus-
pect who required further investigation. By contrast, in the analysis of
‘‘positive sputum culture’’ as a screening tool, we required that M.
tuberculosis was specifically identified.
RESULTS
A total of 2,240 miners were invited to participate in the study,
262 (12%) of whom refused participation. Hence, 1,978 partic-
ipants were screened for tuberculosis. Eighteen participants on
tuberculosis treatment at the time of screening and five partic-
ipants who were found to have nontuberculous mycobacterial
disease on sputum culture during the study were excluded,
leaving 1,955 participants in this analysis.
Participant Demographics
The demographic characteristics of these 1,955 participants are
shown in Table 1. All participants were male, with a median age
of 41 years (range, 20–61 yr) and a median employment duration
of 19 years (range, 1–43 yr). Previous tuberculosis was reported
by 9.8% of participants. Any silicosis (International Labour
Association grade . 0/0) was diagnosed on chest radiograph for
26.0% of participants. HIV prevalence was 29.0% (95% CI,
27.0–31.0%). The HIV-infected participants were more likely to
be younger, have a shorter duration of employment, be non–
South African, and to live in a single-sex hostel; they were also
more likely to report previous tuberculosis. HIV status was not
associated with either working underground or with silicosis.
Prevalence of Positive Screening Criteria
The most common symptoms reported were night sweats
(6.0%), weight loss (5.2%), and cough of any duration (2.5%);
10.7% of miners reported at least one symptom. All symptoms,
TABLE 1. DEMOGRAPHIC CHARACTERISTICS OF STUDY
PARTICIPANTS BY HIV STATUS (N 5 1,955)
HIV-uninfected
(N 5 1,388)
HIV-infected
(N 5 567)
Demographic Variable N % N % P Value
Age group, years
,30 70 5.0 41 7.2 0.001
30–39 470 33.9 234 41.3
40–49 632 45.5 226 39.9
>50 216 15.6 66 11.6
Employment duration, yr
,10 206 14.8 115 20.3 ,0.001
10–19 457 32.9 220 38.8
20–29 559 40.3 176 31.0
>30 166 12.0 56 9.9
Country of origin
South African 729 52.5 250 44.1 0.001
Non–South African 659 47.5 317 55.9
Residence
Non-hostel 370 26.7 122 21.5 0.019
Hostel 1,018 73.3 445 78.5
Place of Work
Surface 93 6.7 43 7.6 0.494
Underground 1,295 93.3 524 92.4
Silicosis
Absent 1,002 72.2 416 73.4 0.751
Early 256 18.4 106 18.7
Advanced 103 7.4 34 6.0
Missing 27 1.9 11 1.9
Previous tuberculosis
No 1,280 92.2 484 85.4 ,0.001
Yes 108 7.8 83 14.6
P values are from a Fisher exact test for differences in characteristics by HIV
status. Silicosis categories were: absent (International Labour Organization [ILO]
grade: 0/0), early (ILO grade: 0/1 or 1/0), or advanced (ILO grade: 1/1, 2/2 or 3/3).
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except hemoptysis, were more common among HIV-infected
participants, but there was strong evidence for an association
with HIV status only for sputum production, night sweats, and
weight loss (Table 2). Thirty-eight participants (1.9%) had
a new or changing chest radiographic abnormality, with no
difference by HIV status (P . 0.999). Thirty-two participants
(1.6%) had at least one positive sputum smear at screening,
again with no difference by HIV status (P 5 0.844). Forty
participants (2.0%) had at least one positive culture for M.
tuberculosis at screening and this was more common among
HIV-infected participants than HIV-uninfected participants
(3.2% vs. 1.6%, respectively; P 5 0.033).
There were 282 participants (14.4%) with at least one
positive screening criterion who hence required further in-
vestigation. The median time from screening visit to review
visit among all tuberculosis suspects was 59 days (interquartile
range, 43–77 d) due to the long delay in obtaining Lo¨wenstein-
Jensen culture results.
Characteristics of Tuberculosis Cases
There were 51 definite (20/51 [39.2%] HIV-infected) and no
presumed cases of tuberculosis (see Table E1 in the online
supplement). None of these tuberculosis cases were exclusively
extrapulmonary. At screening, 15 of the 51 (29.4%) tuberculosis
cases were symptomatic, 10 were asymptomatic with new or
changing radiographic abnormalities (19.6%), and 26 were
asymptomatic with no new or changing radiographic abnormal-
ities (51.0%) (7 smear positive and 19 smear negative, detected
by culture); these proportions did not differ by smear status
(Fisher exact test P. 0.999). By the time of the review visit, this
had changed to 22 of 47 tuberculosis cases being symptomatic
(47%; review data were missing for four tuberculosis cases), 21
being asymptomatic with new or changing radiographic abnor-
malities (45%), and only 4 remaining asymptomatic with no
new or changing radiographic abnormalities (9%; these 4 met
case definitions by bacteriological confirmation). Only 13 of the
51 (25.5%) tuberculosis cases were smear positive at screening
(8/31 for HIV-uninfected and 5/20 for HIV-infected; Fisher
exact test P . 0.999). Ten of the 13 smear-positive and 17 of the
38 smear-negative cases at screening were smear positive at
review, and so a total of 52.9% (27/51) of the tuberculosis cases
were smear positive at review (18/31 for HIV-uninfected and
9/20 for HIV-infected; Fisher exact test P 5 0.402).
Performance of Screening Methods
The usefulness of the various screening methods depends on
their sensitivity and specificity, which may be expected to differ
by HIV status. Hence, these are shown by HIV status in Table
3. Sensitivity did not differ by HIV status for any of the
screening methods. The three most sensitive symptoms were:
new or worsening cough, regardless of duration; night sweats;
and weight loss. The combination of these three symptoms is
referred to as the symptom trio. Presence of at least one of the
symptom trio gave a sensitivity of 29.4%, which was similar to
that of new or changing radiographic abnormalities (25.5%) or
smear positivity (25.5%) and did not differ by HIV status. The
sensitivity of culture positivity at screening was substantially
higher at 78.4%, although this was not 100% because some of
those who were culture negative at screening had positive
cultures at the review visit. Specificity of the symptom trio
(90.7%) was lower than for new or changing radiographic
abnormalities (98.7%), smear positivity (99.0%), or culture
positivity (100.0%). Specificity of the symptom trio was higher
in HIV-uninfected participants than HIV-infected participants
(91.8% vs. 88.2%; P 5 0.018). The specificities of new or
changing radiographic abnormalities, smear positivity, and
culture positivity did not differ by HIV status.
Combining the results from two sputum smears did not
greatly increase the sensitivity from that of the first or second
sputum smear alone (combining HIV-infected and HIV-un-
infected in Table 3: 25.5% vs. 23.5% and 23.5%, respectively).
In contrast, combining the results from two cultures increased
the sensitivity from 66.7% and 64.7% (first and second cultures,
respectively) to 78.4%. Specificities were unchanged by com-
bining either two sputum smear results or two culture results
(Table 3). There were 19 participants with positive smear results
at screening who did not meet case definition for tuberculosis,
none of whom had any positive cultures at screening or review;
of these, 5 were scanty on one of the smears (the other smear
being negative) and 14 were scanty on both smears. In contrast,
for the 13 participants with positive smear results at screening
who did fulfill case definitions, 2 were scanty on one of the
smears, 3 were scanty on both smears, 7 were 11 on both
smears, and 1 participant was 31 on both smears.
Some participants reported more than one symptom (4.8%
of HIV-infected and 2.6% of HIV-uninfected; P 5 0.017).
Hence, logistic regression was used to determine which symp-
toms were independently predictive of tuberculosis (Table 4). In
a multivariable logistic regression of all six symptoms, there
were strong associations between tuberculosis and both new or
worsening cough and night sweats; these associations were not
confounded by HIV, previous tuberculosis, or any silicosis
(Table 4). A separate multivariable logistic regression contain-
TABLE 2. PREVALENCE OF SYMPTOMS, CHEST RADIOGRAPH
ABNORMALITIES, AND LABORATORY FINDINGS AT SCREENING,
BY HIV STATUS (N 5 1,955)
HIV-uninfected
(N 5 1,388)
HIV-infected
(N 5 567)
Screening Method N % N % P Value
Symptom
New or worsening cough
Any duration 29 2.1 20 3.5 0.079
.2 wk 12 0.9 9 1.6 0.224
.3 wk 9 0.7 9 1.6 0.065
New or worsening sputum
production
12 0.9 13 2.3 0.015
Hemoptysis 11 0.8 3 0.5 0.769
Night sweats 69 5.0 49 8.6 0.003
Fever
Any duration 19 1.4 11 1.9 0.417
.2 wk 6 0.4 4 0.7 0.488
.3 wk 6 0.4 4 0.7 0.488
Weight loss .5kg 62 4.5 39 6.9 0.032
At least one symptom 133 9.6 75 13.2 0.023
New or changing radiological
abnormality
27 1.9 11 1.9 .0.999
Smear positive
First specimen 19 1.4 10 1.8 0.538
Second specimen 22 1.6 6 1.1 0.529
Combined 22 1.6 10 1.8 0.844
Culture positive
First specimen 18 1.3 16 2.8 0.034
Second specimen 20 1.4 13 2.3 0.181
Combined 22 1.6 18 3.2 0.033
P values are from a Fisher exact test for differences in prevalences by HIV status.
Data on presence of cough, hemoptysis or night sweats were missing for each of
three separate HIV-uninfected participants. Data on duration of cough were
missing for five HIV-uninfected participants and one HIV-infected participant.
Data on duration of fever were missing for three HIV-uninfected participants and
two HIV-infected participants.
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ing just new or worsening cough and night sweats showed that
these associations remained strong (OR for cough, 3.6; 95% CI,
1.3–9.8; OR for night sweats, 3.7; 95% CI, 1.6–8.3). Dropping
weight loss from the symptom trio reduced sensitivity from 29.4
to 27.5% and increased specificity from 90.7 to 93.6%. As the
focus of this article is active case finding and this symptom trio
has been reported in many other articles, loss of weight was
retained in the symptom combination under evaluation.
Sensitivities of the four screening methods did not differ by
presence or absence of silicosis (data not shown; all P values .
0.3) or reported previous tuberculosis (data not shown; all P
values . 0.15). Specificities of both symptom trio and new or
changing radiographic abnormalities were lower in the presence
of silicosis than in its absence (87.7% vs. 91.9%, P 5 0.008; and
97.1% vs. 99.3%, P , 0.001, respectively). Specificity of smear
did not differ by presence or absence of silicosis (P . 0.999).
Specificity of the symptom trio was lower in the presence of
reported previous tuberculosis than in its absence (83.2% vs.
91.6%; P 5 0.001), whereas the specificities of new or changing
radiographic abnormalities and sputum smear did not differ by
presence or absence of reported previous tuberculosis (P. 0.1).
The addition of various combinations of new or changing
radiographic abnormalities, smear, and/or culture to the symp-
tom trio may substantially improve its sensitivity, without major
loss of specificity. The performances of various combinations
are given in Table 5. Combining symptom trio with either new
or changing radiographic abnormalities or smear positivity gives
an almost additive increase in sensitivity, with very little
TABLE 3. SENSITIVITY AND SPECIFICITY OF SYMPTOMS AND INVESTIGATIONS AT SCREENING FOR ACTIVE CASE FINDING OF
PULMONARY TUBERCULOSIS, BY HIV STATUS
Sensitivity (95% CI) Specificity (95% CI)
Screening Method
HIV-uninfected
(N 5 31)
HIV-infected
(N 5 20) P Value
HIV-uninfected
(N 5 1347)
HIV-infected
(N 5 544) P Value
Symptom
New or worsening cough
Any duration 16.1 (5.5–33.7) 15.0 (3.2–37.9) .0.999 98.6 (97.8–99.1) 97.1 (95.3–98.3) 0.036
.2 wk 9.7 (2.0–25.8) 5.0 (0.1–24.9) .0.999 99.3 (98.7–99.7) 98.5 (97.1–99.4) 0.108
.3 wk 6.5 (0.8–21.4) 5.0 (0.1–24.9) .0.999 99.5 (98.9–99.8) 98.5 (97.1–99.4) 0.045
New or worsening sputum production 16.1 (5.5–33.7) 0.0 (0.0–16.8) 0.143 99.5 (98.9–99.8) 97.6 (95.9–98.7) 0.001
Hemoptysis 6.5 (0.8–21.4) 0.0 (0.0–16.8) 0.514 99.3 (98.7–99.7) 99.4 (98.4–99.9) 1
Night sweats 25.8 (11.9–44.6) 25.0 (8.7–49.1) .0.999 95.6 (94.4–96.6) 92.1 (89.5–94.2) 0.003
Fever
Any duration 6.5 (0.8–21.4) 0.0 (0.0–16.8) 0.514 99 (98.3–99.4) 98.3 (96.9–99.2) 0.257
.2 wk 6.5 (0.8–21.4) 0.0 (0.0–16.8) 0.514 99.7 (99.2–99.9) 99.3 (98.1–99.8) 0.238
.3 wk 6.5 (0.8–21.4) 0.0 (0.0–16.8) 0.514 99.7 (99.2–99.9) 99.3 (98.1–99.8) 0.238
Weight loss .5kg 19.4 (7.5–37.5) 10.0 (1.2–31.7) 0.456 95.9 (94.7–96.9) 93.6 (91.2–95.5) 0.032
>1 symptom 29 (14.2–48.0) 30.0 (11.9–54.3) .0.999 91.3 (89.7–92.8) 87.9 (84.8–90.5) 0.025
Symptom trio* 29 (14.2–48.0) 30.0 (11.9–54.3) .0.999 91.8 (90.2–93.2) 88.2 (85.2–90.8) 0.018
New or changing radiological abnormality 25.8 (11.9–44.6) 25.0 (8.7–49.1) .0.999 98.6 (97.8–99.1) 98.9 (97.6–99.6) 0.824
Smear positive
First specimen 22.6 (9.6–41.1) 25.0 (8.7–49.1) .0.999 99.1 (98.4–99.5) 99.1 (97.9–99.7) . 0.999
Second specimen 25.8 (11.9–44.6) 20.0 (5.7–43.7) 0.743 99.0 (98.3–99.4) 99.6 (98.7–100.0) 0.176
Combined 25.8 (11.9–44.6) 25.0 (8.7–49.1) .0.999 99.0 (98.3–99.4) 99.1 (97.9–99.7) . 0.999
Culture positive
First specimen 58.1 (39.1–75.5) 80.0 (56.3–94.3) 0.135 100.0 (99.7–100.0) 100.0 (99.3–100.0) —
Second specimen 64.5 (45.4–80.8) 65.0 (40.8–84.6) .0.999 100.0 (99.7–100.0) 100.0 (99.3–100.0) —
Combined 71 (52.0–85.8) 90.0 (68.3–98.8) 0.166 100.0 (99.7–100.0) 100.0 (99.3–100.0) —
Definition of abbreviation: CI 5 confidence interval.
There were 13 participants who were missing data on at least one of these screening methods; they have been removed from this analysis.
* At least one of new or worsening cough (any duration), night sweats, or weight loss.
TABLE 4. LOGISTIC REGRESSION ANALYSIS OF SYMPTOMS AT SCREENING AS PREDICTORS OF PULMONARY
TUBERCULOSIS (N 5 1,914)
Univariable Multivariable
Predictor of Pulmonary Tuberculosis OR 95% CI P Value OR 95% CI P Value
New or worsening cough 8.48 (3.75–19.20) ,0.001 3.72 (0.90–15.39) 0.069
New or worsening sputum production 10.02 (3.60–27.85) ,0.001 0.93 (0.17–4.90) 0.927
Hemoptysis 6.30 (1.37–28.89) 0.018 1.12 (0.19–6.67) 0.902
Night sweats 5.79 (2.99–11.20) ,0.001 3.63 (1.55–8.52) 0.003
Fever 2.67 (0.62–11.54) 0.187 0.46 (0.08–2.56) 0.379
Weight loss 3.62 (1.65–7.93) 0.001 1.32 (0.45–3.84) 0.612
HIV 1.60 (0.90–2.83) 0.108 1.46 (0.80–2.64) 0.215
Previous tuberculosis 1.22 (0.52–2.91) 0.647 0.74 (0.29–1.91) 0.535
Any silicosis 1.57 (0.87–2.81) 0.131 1.55 (0.84–2.85) 0.162
Definition of abbreviations: CI 5 confidence interval; OR 5 odds ratio.
There were 41 participants who had missing data on at least one of these predictors; they were removed from the analysis. All variables were included in the
multivariable analysis.
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decrease in specificity. The combination of symptom trio, new
or changing radiographic abnormalities, smear, and culture
gives a very high sensitivity (98.0%) with reasonable specificity
(88.6%).
The positive and negative predictive values are given in
Table 5. The positive predictive values of symptom trio, new or
changing radiographic abnormalities, and smear positivity were
low (all ,41%), which would result in a large number of
tuberculosis suspects being unnecessarily investigated further.
The negative predictive values were all very high (lowest 5
97.9%).
Sensitivity of symptom trio did not differ between the 13
smear-positives at screening (30.8%) and the 38 smear-nega-
tives (29.0%; P . 0.999). Sensitivity of new or changing
radiographic abnormalities was higher among the 13 smear-
positives (38.5%) than the 38 smear-negatives (21.1%), but the
difference was not statistically significant (P 5 0.274), possibly
due to low power.
DISCUSSION
In order for community-based, active case finding for tubercu-
losis to be efficient in high HIV prevalence settings, the
performance of the algorithm used for tuberculosis screening
should be unaffected by HIV status. For active tuberculosis case
finding the screening algorithm should have a high sensitivity, to
ensure that as few tuberculosis cases as possible are missed, and
a high specificity, to minimize the number of tuberculosis
suspects investigated inappropriately for tuberculosis, thereby
reducing costs and the burden on the laboratories.
The main findings of this study are that adding chest
radiography (defined as new or changing radiographic abnor-
malities) to symptom screening substantially improved the
sensitivity of the screening tool, compared with symptom
screening alone, as seen in some other studies (15, 16), and
that tuberculosis screening was not substantially affected by
HIV status.
This study was conducted before antiretroviral therapy was
available in South Africa outside of private clinics or clinical
trials and so it is extremely unlikely that any of the participants
would have been taking antiretroviral therapy. CD4 counts
were not determined among HIV-infected participants in this
study, preventing investigation of the impact of immunosup-
pression. Although the number of tuberculosis cases was rel-
atively small, the sensitivities were generally similar by HIV
status, suggesting that low statistical power to detect differences
was unlikely to have biased the conclusions. Specificity was
lower in HIV-infected than HIV-uninfected participants; this
may be because a greater proportion of HIV-infected than
HIV-uninfected participants who did not have tuberculosis
nonetheless had symptoms and new or changing radiographic
abnormalities suggestive of tuberculosis.
In this study, around half of undiagnosed tuberculosis cases
(26 of 51) found by active case finding were both asymptomatic
and with no new or changing radiological abnormalities at
screening. However, at the review visit, disease progression
was clear with only four cases still asymptomatic with no new or
changing radiological abnormalities (but confirmed bacteriolog-
ically). In addition, at screening only 13 of 51 tuberculosis cases
were smear positive and these 13 had a low degree of smear
positivity (5 were scanty, 7 were 11, and only 1 was 31). Yet, in
the interval between screening and review, 17 of the 38 smear-
negative cases became smear positive. These results are similar
to those from a study screening 4,668 employees of 22 busi-
nesses in Harare, Zimbabwe for prevalent tuberculosis disease.
This study detected active tuberculosis in 27 employees (0.5%),
11 of whom were detected only through culture, yet by follow-
up, symptoms had developed in all but two participants (17).
This provides strong evidence that active case finding contrib-
utes to tuberculosis control by finding cases earlier and so
reducing the duration of infectiousness. It also suggests that
during active case finding, scanty positives should be investi-
gated further, as many of these may be tuberculosis cases in
early stages of disease.
Chest radiography was used extensively for tuberculosis case
finding in Europe, Canada, Japan, and the United States during
the 20th century and contributed to the control of tuberculosis
in these countries (18). Consistent with the results from this
study, a tuberculosis survey done in two Cape Town communi-
ties found that the addition of chest radiography to symptom
screening increased the sensitivity from 69% for symptom
screening alone to 90% for combined symptom and chest
radiography screening (16). Although radiographic facilities
are scarce in resource-limited settings, affordable, mobile,
digital chest radiographic units are becoming available that will
enable mass tuberculosis screening in some resource-limited
settings, with appropriate infrastructure, and this should im-
prove the performance of active tuberculosis case finding when
combined with symptom screening. Although the combination
of symptoms, chest radiography, and sputum microscopy and
TABLE 5. SENSITIVITY AND SPECIFICITY OF COMBINATIONS OF SYMPTOMS AND INVESTIGATIONS AT SCREENING FOR THE ACTIVE
CASE FINDING OF PULMONARY TUBERCULOSIS
Combinations of Screening Methods
Prevalence of Criterion
(N 5 1,953)
Sensitivity (95% CI)
(N 5 51)
Specificity (95% CI)
(N 5 1,902)
PPV
(95% CI)
NPV
(95% CI)
Symptom trio* 199 (10.2%) 29.4 (17.5–43.8) 90.3 (88.9–91.6) 7.5 (4.3–12.1) 97.9 (97.2–98.6)
New chest radiograph abnormality 38 (2.0%) 25.5 (14.3–39.6) 98.7 (98.1–99.1) 34.2 (19.6–51.4) 98.0 (97.3–98.6)
Smear positive 32 (1.6%) 25.5 (14.3–39.6) 99.0 (98.4–99.4) 40.6 (23.7–59.4) 98.0 (97.3–98.6)
Culture positive 40 (2.1%) 78.4 (64.7–88.7) 100.0 (99.8–100.0) 100.0 (91.2–100.0) 99.4 (99.0–99.7)
Symptom trio and/or CXR 226 (11.6%) 49.0 (34.8–63.4) 89.4 (88.0–90.8) 11.1 (7.3–15.9) 98.5 (97.8–99.0)
Symptom trio and/or smear positive 224 (11.5%) 47.1 (32.9–61.5) 89.5 (88.0–90.8) 10.7 (7.0–15.5) 98.4 (97.7–99.0)
Symptom trio and/or CXR and/or smear positive 248 (12.7%) 62.7 (48.1–75.9) 88.6 (87.1–90.0) 12.9 (9.0–17.7) 98.9 (98.3–99.3)
Symptom trio and/or smear positive and/or
culture positive
245 (12.5%) 88.2 (76.1–95.6) 89.5 (88.0–90.8) 18.4 (13.7–23.8) 99.6 (99.2–99.9)
Symptom trio and/or CXR and/or smear positive
and/or culture positive
266 (13.6%) 98.0 (89.6–100.0) 88.6 (87.1–90.0) 18.8 (14.3–24.0) 99.9 (99.7–100.0)
Definition of abbreviations: CI 5 confidence interval; CXR 5 new or changing radiological abnormality; NPV 5 negative predictive value; PPV 5 positive predictive
value.
There were two participants who were missing data on at least one of these screening methods; they have been removed from this analysis.
* At least one of new or worsening cough (any duration), night sweats, or weight loss.
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culture provides the best sensitivity and further improves the
positive predictive value, it would not be generalizable as
microscopy services are already overloaded and few resource-
limited countries have culture facilities.
It is notable that in this study the sensitivity of new or changing
radiographic abnormalities alone (25.5%) was considerably lower
than that reported in other populations (15, 16) but is similar to that
reported in a study of screening for tuberculosis in adults with
advanced HIV infection (19). This low sensitivity may in part
reflect the difficulties of identifying tuberculosis against a back-
ground of occupational lung disease in this mining population or
a lower sensitivity of mini chest radiographs compared with
standard size chest radiographs. Alternatively this observation
could indicate that sensitivity may change with time when any
given screening tool is repeatedly applied to the same population.
Figure 1 illustrates how such a situation could arise if a substantial
fraction of undetected tuberculosis remains active but untreated
for a substantially longer period than the interval between
successive screens. This demonstrates that secular changes in the
sensitivity of a screening tool can be expected if it is used repeatedly
in the same population. The decreasing sensitivity should not be
taken as an indication to stop the screening program, but rather
Figure 1. Schematic of the likely impact of an
annual active case-finding program of symptom
screen and chest radiograph on tuberculosis prev-
alence and sensitivity of the screening. Prevalent
tuberculosis is divided into symptomatic tubercu-
losis disease, asymptomatic tuberculosis disease
with radiographic abnormalities, and asymptom-
atic tuberculosis disease with no radiographic
abnormalities. Assumptions: (1) Tuberculosis prev-
alence at final year is 2.5% and is 30% symptom-
atic, 20% asymptomatic with radiographic
abnormalities, and 50% asymptomatic with no
radiographic abnormalities, as reported in this
article. (2) This is assumed to represent an open
cohort of miners who are regularly screened for
tuberculosis when joining the workforce and then
at regular intervals after this. Hence, prevalence of
tuberculosis disease that is asymptomatic with no
radiographic abnormalities has remained static in
the presence of the screening program. (3) The
screening program has reduced the prevalence of
symptomatic disease and asymptomatic disease
with radiographic abnormalities at the same con-
stant rate, producing the same linear trend in declining prevalence. (4) Sensitivity of the screening program is defined as the proportion of disease
that is symptomatic plus the proportion of disease that is asymptomatic with radiographic abnormalities (i.e., it is the proportion of all true active
disease that can be detected by symptom and radiographic screening). (5) For illustrative purposes, it is assumed that tuberculosis prevalence was
5% before the screening program. CRX 5 new or changing radiological abnormality; TB 5 tuberculosis.
TABLE 6. PERFORMANCE OF TUBERCULOSIS SYMPTOM SCREENING IN DIFFERENT SOUTHERN AFRICAN SETTINGS
Author, Year Location N
HIV
Prevalence (%) Symptoms Included Gold Standard
Sensitivity
(%)
Specificity
(%)
Communities
Corbett, 2008 (20) Harare 8,979 21 Cough, weight loss, fever,
hemoptysis, night sweats
Case definitions applied* 77 89
den Boon, 2006 (16) Cape Town 1,170 ,12† Cough, hemoptysis, night
sweats, fever, weight loss
Positive smear or
culture at screening
69 68
Wood, 2007 (21) Cape Town 762 23 Cough, night sweats, loss of
appetite, loss of weight
2 positive smears or
cultures at screening
33 74‡
Workplaces
Corbett, 2007 (17) Harare factory
workers
4,668 19 Cough, fever, hemoptysis, night
sweats, unintentional weight loss
Case definitions applied* 59 —
Lewisx South African
gold miners
1,905 29 New or worsening cough (any
duration), night sweats, weight loss
Case definitions applied* 31 90
HIV clinics
Mohammed, 2004 (19) Cape Town HIV clinic,
WHO stage III or IV
129 100 .1 of measured weight loss,
cough, night sweats, or fever
Positive screening culture and
symptoms or CXR
100 88.1
Day, 2006 (15)k South African
gold miners
899 100 Cough, night sweats, weight loss Case definitions applied* 59 76
Definition of abbreviations: CXR 5 chest radiographic abnormalities; WHO 5 World Health Organization.
* Case definitions used screening and follow-up results from clinical examination, chest radiographic abnormalities, smear, and culture.
† HIV testing was not done; HIV prevalence in this population was assumed to be less than the 12% reported from local antenatal clinics.
‡ Not able to calculate specificity as proportion with one or more symptom that did not have tuberculosis was not specified. Specificity for loss of weight reported as it
had the highest specificity.
x This study.
k Results did not differ by CD4 count.
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that the program is working by reducing the proportion of true
active tuberculosis cases that are detectable using the screening
tool after successive rounds of screening (assuming correct sub-
sequent treatment). Another possible, but highly speculative,
explanation is that the selective pressure of approximately 50 years
of radiological screening in this population has pushed the
circulating tuberculosis strains toward ones that are less readily
detectable by radiological screening.
The sensitivity of symptom screening for active tuberculosis
case finding varies markedly in different communities, work-
place settings, and in HIV clinic patients (Table 6) (20, 21). The
explanation for the large differences in sensitivity and specificity
of symptom screening seen in these studies, all based in
Southern Africa, is likely to be multifactorial and may include:
differences in study populations, such as mining versus general
populations and the proportion HIV-infected; the screening
algorithms used; and the case definitions of tuberculosis used.
For example, four of the seven studies (including this study)
used follow-up data when applying case definitions to reduce
the problem of false-negative cultures, whereas the other three
were restricted to screening data only. One of the seven studies
used spoligotyping to reduce the potential problem of labora-
tory cross-contamination. In addition, the presence or absence
of routine screening for tuberculosis in the population is likely
to play an important role, although currently this is mostly
restricted to mining populations.
The generalizability of our results may be limited because
gold miners are regularly screened for tuberculosis, which
would reduce the prevalence of undiagnosed active disease,
and the definition of cough was restricted to a ‘‘new or
worsening cough’’ regardless of duration. However, the minimal
impact of HIV status, silicosis, or previous tuberculosis on the
performance of the screening methods is likely to be generaliz-
able. The generalizability of our findings concerning the value
of chest radiography as a screening tool may be questioned
because (1) silicosis is prevalent, and (2) chest radiography
results were classified as new or changing abnormalities in
comparison to a previous chest radiograph. However, silicosis
is slowly progressive over many years (22), whereas radiological
changes of active tuberculosis evolve over 6 to 12 months (17).
Therefore, comparing the screening radiograph to a film taken
about 1 year earlier, new changes would be much more likely to
represent TB than silicosis. Hence, the results are more
generalizable than may be first assumed.
We do not know reasons for nonparticipation in this study;
however, it was done in conjunction with a study of sexually
transmitted infections that required examination of genitalia
and we suspect this was the main reason for nonparticipation.
This is unlikely to have biased our results and the uptake of
88% is reasonable. The strengths of this study include a gold
standard definition of tuberculosis based on culture, a large
sample size, and wide inclusion criteria.
Conclusions
The addition of chest radiography to symptom screening sub-
stantially improved the sensitivity of the screening tool in this
population of gold miners. Furthermore, our findings suggest
that the usefulness of this screening strategy will be retained in
high HIV prevalence settings. Community-wide active case
finding for tuberculosis may contribute to reducing tuberculosis
transmission by reducing the duration of infectiousness. Secular
changes in the sensitivity of the strategy should be anticipated if
repeated screening rounds are performed. Further research is
required to develop more sensitive, field-friendly tuberculosis
screening tools.
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